JP Morgan Private Wealth Advisors’s Clovis Oncology, Inc. CLVS Stock Holding History

JP Morgan Private Wealth Advisors’s Portfolio CLVS Stock Details CLVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-22,000	Closed	-$40K	–	2004
2022 Q2	$40K	Buy	22,000 +8,405	+62%	+$12.4K	﹤0.01%	1898
2022 Q1	$27K	Buy	+13,595	New	+$26.7K	﹤0.01%	1969
2021 Q4	–	Sell	-43,485	Closed	-$194K	–	2058
2021 Q3	$194K	Buy	43,485 +2,000	+5%	+$9.63K	﹤0.01%	1869
2021 Q2	$241K	Buy	+41,485	New	+$243K	﹤0.01%	1764
2021 Q1	–	Sell	-19,870	Closed	-$95K	–	1813
2020 Q4	$95K	Buy	+19,870	New	+$101K	﹤0.01%	1682
2018 Q1	–	Sell	-3,186	Closed	-$217K	–	1399
2017 Q4	$217K	Buy	3,186 +144	+5%	+$10.1K	﹤0.01%	1165
2017 Q3	$251K	Buy	+3,042	New	+$241K	﹤0.01%	1084
2017 Q2	–	Sell	-3,269	Closed	-$208K	–	1375
2017 Q1	$208K	Buy	+3,269	New	+$199K	﹤0.01%	1228

Other funds holding CLVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Private Wealth Advisors's CLVS Position: Q3 2022 in Review

JP Morgan Private Wealth Advisors sold out of Clovis Oncology, Inc. (CLVS) in Q3 2022, closing a stake of 22,000 shares — an estimated $40K sold.

JP Morgan Private Wealth Advisors first reported a position in CLVS in Q1 2017 and held it in 8 quarters. The position peaked at $251K in Q3 2017. 103 funds tracked by Wall St. Rank hold CLVS as of Q3 2022.

JP Morgan Private Wealth Advisors reported no remaining Clovis Oncology, Inc. position as of Q3 2022 after selling out during the quarter.
JP Morgan Private Wealth Advisors sold 22,000 Clovis Oncology, Inc. shares in Q3 2022, an estimated $40K.
JP Morgan Private Wealth Advisors first reported a position in Clovis Oncology, Inc. in Q1 2017 and held it in 8 quarters.
JP Morgan Private Wealth Advisors's Clovis Oncology, Inc. position peaked at $251K in Q3 2017.
103 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q3 2022.

Based on JP Morgan Private Wealth Advisors's 13F filing for Q3 2022, filed 4 Nov 2022.